CJD and the eye

Eye (Basingstoke)

Volumn 14, Issue 3, 2000, Pages 259-260

  Tullo, Andrew ^a   Buckley, Roger ^a   Painter, Mike ^b  

^a ROYAL COLLEGE OF OPHTHALMOLOGISTS   (United Kingdom)

^b Gateway House   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

BRAIN RADIOGRAPHY; CLINICAL FEATURE; CORNEA EPITHELIUM; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; EDITORIAL; ELECTRODE; EYE; EYE SURGERY; HUMAN; MEDICAL PRACTICE; NEUROSURGERY; OPHTHALMOLOGY; OPTOMETRY; PRION DISEASE; SURGICAL INSTRUMENT; TRIGEMINUS GANGLION; VISUAL DISORDER;

EID: 0033924773     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2000.73     Document Type: Editorial

References (23)

1. Prusiner SB. The prion disease. Sci Am 1995; 272: 30-7.
2. Taylor DM. Inactivation of SE agents. Br Med Bull 1993; 49: 810-21.
3. Wells GAH, Scott AC, Johnson CT, Gunning RF, Hancock RD, Jeffrey M, A novel progressive spongiform encephalopathy in cattle. Vet Rec 1987; 121: 419-20.
4. Southwood R. Report of the working party on bovine spongiform encephalopathy. London: HMSO, 1989.
5. The Bovine Spongiform Encephalopathy Order 1988. Statutory Instrument 1039. London: HMSO, 1988.
6. The Bovine Offal (Prohibitation) Regulations 1989. Statutory Instrument 2061. London: HMSO, 1989.
7. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 790-1. http:/www.maf.gov.uk/animalh/bse/index/html.
8. Deslys JP, Lasmezas CL, Streichenberger N, Hill A, Collinge J, Dormont D, New variant Creutzfeldt-Jakob disease in France. Lancet 1997; 349: 30-1.
9. The Irish Times. Dublin: 26 August 1999.
10. Ghani AC, Ferguson N, Donnelly CA, Hagenaars TJ, Anderson RM. Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain. Proc R Soc Lond 1998; 265: 2443-52.
11. Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997; 349: 99-100.
12. Hilton DA, Fathers E, Edwards P, Ironside W, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998; 352: 703-4.
13. Tullo AB. CJD and the Eye. Focus, Royal College of Ophthalmologists, Autumn 1998; 1-2.
14. Allan B, Tuft S. Transmission of Creutzfeldt-Jakob disease in corneal grafts. BMJ 1997; 315: 1553-4.
15. Duffy P, Wolf J, Collins G, Devoe AG, Streen B, Cowen D. Possible person-ta-person transmission of Creutzfeldt-Jakob Disease. N Engl J Med 1974; 290: 692-3.
16. Brown P, Preece MA, Will RG. 'Friendly fire' in medicine: hormones, homografts and Creutzfeldt-Jakob disease. Lancet 1992; 340: 24-7. www.rcophth.ac.uk
17. Lueck CJ, McIlwaine G, Zeidler M. Creutzfeldt-Jakob disease. II. Ophthalmic and neuro-ophthalmic features. Eye 2000; 14: 291-301.
18. Lueck CJ, McIlwaine GC, Zeidler M. Creutzfeldt-Jakob disease and the eye. I. Background and patient management. Eye 2000; 14: 263-90.
19. Guiroy DC, Shankar SK, Gibbs Q, Messenheimer JA, Dass S, Gajdusek DC. Neuronal degeneration and neurofilament accumulation in the trigeminal ganglia in Creutzfeldt-Jakob disease. Ann Neurol 1989; 25: 102-6.
20. Marsh RE, Anson RP. Transmissible mink encephalopathy infectivity of corneal epithelium. Science 1975; 187: 656.
21. Ingrosso L, Pisani F, Pocchiari M. Transmission of the 263K scrapie strain by the dental route. J Gen Virol 1999; 80: 3043-7
22. Medical Devices Agency MDA AN 1999 (04).
23. Tullo AB, Taylor DM. CJD and ophthalmic instruments [letter]. Br J Ophthalmol. 2000; in press.